METHODS OF USING THE CALCINEURIN A VARIANT CNAß1 FOR THE TREATMENT OF CARDIAC HYPERTROPHY

摘要

The present invention relates to an activator of the calcineurin subunit A&bgr;1 isofomi (CnA&bgr;1) or of the C-terminal domain of the calcineurin subunit A&bgr;1 isofomi (CnA&bgr;1) for the production of a medicament for the modulation of myocardial growth without adversely affecting contractile function.